Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
or

Abbott Laboratories (ABT)

Abbott Laboratories (ABT)
129.36 x 1 131.00 x 1
Post-market by (Cboe BZX)
129.38 -0.46 (-0.35%) 04/24/25 [NYSE]
129.36 x 1 131.00 x 1
Post-market 129.41 +0.03 (+0.02%) 18:47 ET
Profile for Thu, Apr 24th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.

Company Info

Abbott Laboratories 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064 USA

www.abbott.com Employees: 114,000 P: 224-667-6100

Sector:

Medical

Description:

Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson.

Key Statistics

Overview:

Market Capitalization, $K 224,386,720
Enterprise Value, $K 230,895,712
Shares Outstanding, K 1,734,323
Annual Sales, $ 41,950 M
Annual Net Income, $ 13,402 M
Last Quarter Sales, $ 10,358 M
Last Quarter Net Income, $ 1,325 M
EBIT, $ 8,958 M
EBITDA, $ 12,176 M
60-Month Beta 0.80
% of Insider Shareholders 0.46%
% of Institutional Shareholders 75.18%
Float, K 1,726,345
% Float 99.54%
Short Volume Ratio 0.35

Growth:

1-Year Return 21.04%
3-Year Return 13.99%
5-Year Return 44.00%
5-Year Revenue Growth 31.49%
5-Year Earnings Growth 44.14%
5-Year Dividend Growth 71.88%

Per-Share Information:

Most Recent Earnings 1.09 on 04/16/25
Next Earnings Date N/A
Earnings Per Share ttm 4.78
EPS Growth vs. Prev Qtr -18.66%
EPS Growth vs. Prev Year 11.22%
Annual Dividend Rate, $ 2.28
Annual Dividend Yield 1.76%
Most Recent Dividend 0.590 on 04/15/25
Next Ex-Dividends Date 04/15/25
Dividend Payable Date 05/15/25
Dividend Payout Ratio 46.34%
Most Recent Split 2-1 on 01/02/13

ABT Ratios

Ratio
Price/Earnings ttm 27.16
Price/Earnings forward 25.55
Price/Earnings to Growth 2.48
Return-on-Equity % 19.74%
Return-on-Assets % 11.00%
Profit Margin % 31.95%
Debt/Equity 0.29
Price/Sales 5.37
Price/Cash Flow 20.01
Price/Book 4.77
Book Value/Share 27.62
Interest Coverage 13.55

ABT Dividends

Date Value
04/15/25 $0.5900
01/15/25 $0.5900
10/15/24 $0.5500
07/15/24 $0.5500
04/12/24 $0.5500
01/11/24 $0.5500
10/12/23 $0.5100
07/13/23 $0.5100
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective